NO20061470L - Fremgangsmate for fremstilling av gamma-karboksylerte proteiner - Google Patents

Fremgangsmate for fremstilling av gamma-karboksylerte proteiner

Info

Publication number
NO20061470L
NO20061470L NO20061470A NO20061470A NO20061470L NO 20061470 L NO20061470 L NO 20061470L NO 20061470 A NO20061470 A NO 20061470A NO 20061470 A NO20061470 A NO 20061470A NO 20061470 L NO20061470 L NO 20061470L
Authority
NO
Norway
Prior art keywords
gamma
preparation
carboxylated
proteins
protein
Prior art date
Application number
NO20061470A
Other languages
English (en)
Other versions
NO339740B1 (no
Inventor
Ann Lovgren
Anders Thelin
Christel Fenge
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=29559260&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20061470(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of NO20061470L publication Critical patent/NO20061470L/no
Publication of NO339740B1 publication Critical patent/NO339740B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6429—Thrombin (3.4.21.5)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/647—Blood coagulation factors not provided for in a preceding group or according to more than one of the proceeding groups
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21005—Thrombin (3.4.21.5)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

Foreliggende oppfinnelse angår fremgangsmåter og verktøy for fremstilling av store mengder gamma-karboksylert protein ornfattende: (i) dyrkning av en celle tilpasset til å uttrykke et protein som krever gamma-karboksylering og (-glutamyl karboksylase i en ratio på minst 10:1, under betingelser egnet for ekspresjon av begge proteinene og (ii) isolering av gamma-karboksylert protein.
NO20061470A 2003-10-14 2006-03-31 Eukaryot vertscelle som omfatter minst en ekspresjonsvektor, nevnte vektor omfattende et nukleinsyremolekyl, metode for å produsere gamma-karboksylert protein samt metode for å produsere farmasøytisk preparat basert på samme NO339740B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0324044.7A GB0324044D0 (en) 2003-10-14 2003-10-14 Protein
PCT/SE2004/001453 WO2005038019A1 (en) 2003-10-14 2004-10-12 Method for producing gamma-carboxylated proteins

Publications (2)

Publication Number Publication Date
NO20061470L true NO20061470L (no) 2006-05-12
NO339740B1 NO339740B1 (no) 2017-01-30

Family

ID=29559260

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20061470A NO339740B1 (no) 2003-10-14 2006-03-31 Eukaryot vertscelle som omfatter minst en ekspresjonsvektor, nevnte vektor omfattende et nukleinsyremolekyl, metode for å produsere gamma-karboksylert protein samt metode for å produsere farmasøytisk preparat basert på samme

Country Status (29)

Country Link
US (2) US7842477B2 (no)
EP (2) EP2292748B1 (no)
JP (1) JP4658946B2 (no)
KR (1) KR101201020B1 (no)
CN (2) CN1867669B (no)
AR (1) AR046180A1 (no)
AT (1) ATE491789T1 (no)
AU (2) AU2004281350B2 (no)
BR (1) BRPI0415277A (no)
CA (1) CA2541764C (no)
CO (1) CO5690657A2 (no)
DE (1) DE602004030603D1 (no)
DK (1) DK1678297T3 (no)
ES (2) ES2532470T3 (no)
GB (1) GB0324044D0 (no)
HK (1) HK1155475A1 (no)
IL (2) IL174633A (no)
IS (1) IS8447A (no)
MX (1) MXPA06004060A (no)
MY (1) MY141859A (no)
NO (1) NO339740B1 (no)
NZ (2) NZ546584A (no)
PL (1) PL1678297T3 (no)
PT (1) PT1678297E (no)
RU (2) RU2372401C2 (no)
TW (1) TWI355419B (no)
UY (1) UY28558A1 (no)
WO (1) WO2005038019A1 (no)
ZA (1) ZA200603038B (no)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006101474A1 (en) * 2005-03-15 2006-09-28 University Of North Carolina At Chapel Hill Methods and compositions for producing active vitamin k-dependent proteins
EP2336360A1 (en) * 2003-09-23 2011-06-22 University Of North Carolina At Chapel Hill Methods and compositions for the correlation of single nucleotide polymorphisms in the vitamin K epoxide reductase gene and warfarin dosage
GB0324044D0 (en) 2003-10-14 2003-11-19 Astrazeneca Ab Protein
EP1874928A1 (en) 2005-04-13 2008-01-09 AstraZeneca AB A host cell comprising a vector for production of proteins requiring gamma-carboxylation
CA2624072A1 (en) * 2005-09-30 2007-04-12 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Process for producing recombinant human thrombin by cultured cell
US7745484B2 (en) 2005-11-21 2010-06-29 Amgen Inc. Beta-secretase modulators and methods of use
DK1969127T4 (en) * 2005-12-21 2017-10-16 Cnj Holdings Inc Process for the preparation of biologically active vitamin K-dependent proteins by recombinant methods
RU2008139428A (ru) * 2006-03-06 2010-05-20 Хьюмэджин, Инк. (Us) Способ получения рекомбинантного тромбина и фибриногена человека
JP6050927B2 (ja) * 2007-04-26 2016-12-21 シーエヌジェイ ホールディングス，インコーポレイテッド 高シアル酸含量を有する組換えビタミンｋ依存性タンパク質およびその調製方法
US8206967B2 (en) * 2007-07-06 2012-06-26 Medimmune Limited Method for production of recombinant human thrombin
AU2011313505B2 (en) * 2010-10-06 2015-09-17 Medimmune Limited Factor II and fibrinogen for treatment of haemostatic disorders
US9631002B2 (en) 2010-12-21 2017-04-25 The University Of North Carolina At Chapel Hill Methods and compositions for producing active vitamin K-dependent proteins
WO2013036445A1 (en) 2011-09-06 2013-03-14 Medimmune Llc Methods for processing coagulation factors
RU2500816C1 (ru) * 2012-07-19 2013-12-10 Общество с ограниченной ответственностью "Международный биотехнологический центр "Генериум" ("МБЦ "Генериум") РЕКОМБИНАНТНАЯ ПЛАЗМИДНАЯ ДНК рАК380, КОДИРУЮЩАЯ ПОЛИПЕПТИД РЕКОМБИНАНТНОГО ФАКТОРА IХ СВЕРТЫВАЕМОСТИ КРОВИ ЧЕЛОВЕКА, ЛИНИЯ КЛЕТОК Cricetulus griseus CHO 1E6 - ПРОДУЦЕНТ РЕКОМБИНАНТНОГО ФАКТОРА IХ СВЕРТЫВАЕМОСТИ КРОВИ ЧЕЛОВЕКА И СПОСОБ ПОЛУЧЕНИЯ ПОЛИПЕПТИДА, ОБЛАДАЮЩЕГО АКТИВНОСТЬЮ РЕКОМБИНАНТНОГО ФАКТОРА IХ
JP5830486B2 (ja) 2013-03-29 2015-12-09 シスメックス株式会社 組換えバキュロウイルスおよびその利用
PL3083677T3 (pl) * 2013-12-20 2020-03-31 Novartis Ag Nowe komórki eukariotyczne i sposoby rekombinowanej ekspresji produktu będącego przedmiotem zainteresowania
CN109207462B (zh) * 2018-08-01 2021-05-11 深圳市新产业生物医学工程股份有限公司 异常凝血酶原及其制备方法和包含其的检测剂、试剂盒及应用

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3043857A1 (de) 1980-11-21 1982-07-08 Behringwerke Ag, 3550 Marburg Verfahren zur herstellung von blutgerinnungsfaktoren und danach hergestellte praeparation der faktoren ii und vii
US4599308A (en) * 1981-10-06 1986-07-08 Hamer Dean H Protein from SV40 recombinants
EP0173552B1 (en) 1984-08-24 1991-10-09 The Upjohn Company Recombinant dna compounds and the expression of polypeptides such as tpa
GR860984B (en) * 1985-04-17 1986-08-18 Zymogenetics Inc Expression of factor vii and ix activities in mammalian cells
JPH01502080A (ja) 1986-11-17 1989-07-27 ニュー・イングランド・メディカル・センター 組み換えビタミンｋ依存性蛋白質のガンマカルボキシル化の増強
US6224864B1 (en) 1986-12-03 2001-05-01 Pharmacia & Upjohn Company Antibiotic 10381A, and process for the preparation of anitbiotics 10381B
WO1989012685A1 (en) 1987-05-18 1989-12-28 Integrated Genetics, Inc. Improved protein c molecules and method for making and activating same
US5648254A (en) * 1988-01-15 1997-07-15 Zymogenetics, Inc. Co-expression in eukaryotic cells
US5118614A (en) 1988-01-18 1992-06-02 Tessek Sdruzeni Praha Concentrates of coagulation factors ii, vii, ix and x, method of their preparation and use
AU8427091A (en) 1990-07-23 1992-02-18 Zymogenetics Inc. Gamma-carboxylase and methods of use
US5965789A (en) 1991-01-11 1999-10-12 American Red Cross Engineering protein posttranslational modification by PACE/furin in transgenic non-human mammals
US5268275A (en) 1991-05-08 1993-12-07 The University Of North Carolina At Chapel Hill Vitamin K-dependent carboxylase
US5219995A (en) 1992-07-14 1993-06-15 Alpha Therapeutic Corporation Plasma fraction purification
US6015686A (en) 1993-09-15 2000-01-18 Chiron Viagene, Inc. Eukaryotic layered vector initiation systems
US5639661A (en) * 1994-03-23 1997-06-17 The University Of Iowa Research Foundation Genes and proteins for treating cystic fibrosis
DE4430204A1 (de) 1994-08-26 1996-02-29 Behringwerke Ag Arzneimittel, welches als Gegenmittel für Blut-Antikoagulanzien geeignet ist und seine Verwendung
EP0796623B1 (de) 1996-03-20 2005-05-25 Baxter Aktiengesellschaft Pharmazeutisches Präparat zur Behandlung von Blutgerinnungsstörungen
DE69841459D1 (en) * 1997-02-14 2010-03-11 American Nat Red Cross Expression des active human factor ix im brustdrüsengewebe transgener tiere
CA2315879A1 (en) 1997-12-24 1999-07-08 Immunex Corporation V201 dna and polypeptides
US6413737B1 (en) 1999-07-09 2002-07-02 Cohesion Technologies, Inc. Ecarin prothrombin protease and methods
WO2001007068A1 (en) 1999-07-23 2001-02-01 Case Western Reserve University Novel methods and reagents for the treatment of osteoarthritis
AU2001268373A1 (en) * 2000-06-13 2001-12-24 The Children's Hospital Of Philadelphia Methods for administering recombinant adeno-associated virus virions to humans previously exposed to adeno-associated virus
BR0114374A (pt) 2000-10-02 2003-12-30 Novo Nordisk As Preparação compreendendo uma pluralidade de polipeptìdeos de fator vii, métodos para a determinação do padrão de glicoforma de fator vii e de polipeptìdeos relacionados com fator vii, e para a produção da dita preparação, formulação farmacêutica, métodos para o tratamento de uma sìndrome responsiva a fator vii, para a prevenção de sangramento indesejado, para a prevenção de coagulação sanguìnea indesejada, e para prevenção de reações mediadas por fator de tecido, e, uso da preparação
CN100347297C (zh) 2001-07-06 2007-11-07 财团法人化学及血清疗法研究所 利用基因工程技术制备人凝血酶的方法
JP4150814B2 (ja) 2001-07-06 2008-09-17 財団法人化学及血清療法研究所 遺伝子組換えエカリン及びその製造方法
CA2452395C (en) 2001-07-10 2012-04-10 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Pharmaceutically stable hemostatic compositions
EP2336360A1 (en) 2003-09-23 2011-06-22 University Of North Carolina At Chapel Hill Methods and compositions for the correlation of single nucleotide polymorphisms in the vitamin K epoxide reductase gene and warfarin dosage
GB0324044D0 (en) 2003-10-14 2003-11-19 Astrazeneca Ab Protein
ES2344413T3 (es) 2003-10-14 2010-08-26 Baxter International Inc. Polipeptido vkorc1 de reciclaje de la vitamina k-epoxido, una diana terapeutica de la cumarina y sus derivados.
EP1676911B1 (en) 2003-10-24 2010-04-21 Juridical Foundation, The Chemo-Sero-Therapeutic Research Institute Novel recombinant animal cells with high protein production, method of constructing the same and method of mass protein production using the same
EP1831363A1 (en) 2004-12-21 2007-09-12 Novo Nordisk Health Care AG Expression of gamma-carboxylated polypeptides in gamma-carboxylation deficient host systems
EP1874928A1 (en) 2005-04-13 2008-01-09 AstraZeneca AB A host cell comprising a vector for production of proteins requiring gamma-carboxylation
EP1963506B1 (en) 2005-12-02 2010-10-27 Wake Forest University Health Sciences Compositions and methods for increasing production of recombinant gamma-carboxylated proteins
DK1969127T4 (en) 2005-12-21 2017-10-16 Cnj Holdings Inc Process for the preparation of biologically active vitamin K-dependent proteins by recombinant methods
US8206967B2 (en) 2007-07-06 2012-06-26 Medimmune Limited Method for production of recombinant human thrombin

Also Published As

Publication number Publication date
DK1678297T3 (da) 2011-03-14
EP2292748A1 (en) 2011-03-09
NZ546584A (en) 2009-08-28
ATE491789T1 (de) 2011-01-15
CN1867669A (zh) 2006-11-22
UY28558A1 (es) 2005-05-31
CA2541764A1 (en) 2005-04-28
IL174633A0 (en) 2006-08-20
NZ578306A (en) 2011-02-25
JP4658946B2 (ja) 2011-03-23
TWI355419B (en) 2012-01-01
US8697440B2 (en) 2014-04-15
PL1678297T3 (pl) 2011-11-30
TW200523365A (en) 2005-07-16
US20050164367A1 (en) 2005-07-28
WO2005038019A1 (en) 2005-04-28
AU2008205445A1 (en) 2008-09-04
MXPA06004060A (es) 2006-06-28
EP1678297A1 (en) 2006-07-12
CN1867669B (zh) 2011-10-19
CN102443548B (zh) 2014-03-12
EP1678297B1 (en) 2010-12-15
ES2532470T3 (es) 2015-03-27
BRPI0415277A (pt) 2006-12-19
IL226313A0 (en) 2013-06-27
HK1155475A1 (en) 2012-05-18
MY141859A (en) 2010-07-16
KR20060123152A (ko) 2006-12-01
GB0324044D0 (en) 2003-11-19
AU2004281350A1 (en) 2005-04-28
NO339740B1 (no) 2017-01-30
RU2006110147A (ru) 2007-11-20
RU2009123931A (ru) 2010-12-27
US20110092429A1 (en) 2011-04-21
AR046180A1 (es) 2005-11-30
CA2541764C (en) 2015-03-31
CN102443548A (zh) 2012-05-09
DE602004030603D1 (de) 2011-01-27
AU2004281350B2 (en) 2008-05-15
US7842477B2 (en) 2010-11-30
ES2357603T3 (es) 2011-04-28
RU2372401C2 (ru) 2009-11-10
EP2292748B1 (en) 2014-12-17
CO5690657A2 (es) 2006-10-31
PT1678297E (pt) 2011-03-15
IL174633A (en) 2013-06-27
JP2007508820A (ja) 2007-04-12
ZA200603038B (en) 2007-09-26
KR101201020B1 (ko) 2012-11-14
IS8447A (is) 2006-05-10

Similar Documents

Publication Publication Date Title
NO20061470L (no) Fremgangsmate for fremstilling av gamma-karboksylerte proteiner
EP3486314A3 (en) Placental stem cell populations
UA92157C2 (ru) Способ продуцирования гормона роста
SG149061A1 (en) Definitive endoderm
WO2004087896A3 (en) Hepatocyte differentiation of stem cells
HUP0204295A2 (hu) Eljárás L-lizin termelésére
WO2002031134A3 (en) Novel serine protease genes related to dppiv
DE602005006294D1 (de) Reinigungsverfahren für bakterielles cytolysin
EP1180371A4 (en) AGENTS PROMOTING THE FORMATION OF A BASIC SKIN MEMBRANE, AGENTS PROMOTING THE FORMATION OF ARTIFICIAL SKIN AND METHOD FOR PRODUCING ARTIFICIAL SKIN
ATE524161T1 (de) Zusammensetzung mit einem gekoppelten enzymsystem
WO2003104418A3 (en) RECONSTITUTED POLYPEPTIDES
ATE384119T1 (de) Isoprenoidproduktion
WO2006116949A8 (fr) Nouvelle souche du bacillus subtilis et son utilisation dans la préparation de médicament pour traiter la thrombose
DK1546316T3 (da) Mutant E. Coli-AppA-fytaseenzymer og naturlige varianter deraf, nukleinsyrer, der koder for sådanne fytaseenzymer, vektorer og værtsceller, som inkorporerer disse og fremgangsmåder til at fremstille og anvende disse
NO20051841L (no) Fremgangsmate for a oke produksjon av blodplater og hematopoietiske stamceller.
DK1131444T3 (da) Polypeptider med lysophospholipase aktivitet og nucleinsyre som koder for disse
AU2019268061A1 (en) Placental stem cell populations
WO2004050826A3 (en) Method of dynamically culturing embryonic stem cells
HK1097004A1 (en) Novel sequence for improving expression of nucleicacid
GB0208041D0 (en) Method of culturing animal cells
WO2005047494A3 (en) Haematopoietic stem cells suitable for transplantation, their preparation and pharmaceutical compositions comprising them
ATE546521T1 (de) Sesquiterpene synthasen und verwerdungsmethoden
WO2004011637A3 (en) Modified adamts4 molecules and method of use thereof
DE60226896D1 (de) Herstellung von f(ab')2 fragmenten in saügetierzelle
WO2004015091A3 (en) Preparation of type ii pneumocytes from stem cells

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees